Recent searches
Clear History
Suggestions
All Results
Search Procalcitonin & Bacterial Infection
Search
Webinar: Leveraging lessons from 3 decades of Procalcitonin testing: Procalcitonin dos and don'ts. Register now
Thursday, September 5th, 2024 1:00 PM EDT
Case Study
Chronic Obstructive Pulmonary Disease (COPD) vs. Heart Failure (HF) vs. Bacterial Pneumonia (PNA): What is the Diagnosis This Time?
-vs--heart-failure-(hf)-vs--bacterial-pneumonia-(pna)--what-is-the-diagnosis-this-time-/Body Image - High NPV@2x.png)
Michael R. Broyles
PharmD – Director of Medical Affairs, Thermo Fisher Scientific
*NT-proBNP values vary by manufacturer and are age dependent, thus the, +2, +3, etc. are times the normal values.
AECOPD: acute exacerbation of chronic obstructive pulmonary disease.
SOB: shortness of breath.
WNL: within normal limit.
Learn more about implementing procalcitonin testing
in your hospital.
Share your Clinical Experience
Submit your own PCT Case Study and you may be selected to be featured on procalcitonin.com.
Related Resources
Antibiotic Stewardship
Learn how antibiotic stewardship can help protect patients. Discover how to prevent the overuse of antibiotics to combat resistance.
What is Procalcitonin?
What is procalcitonin (PCT)? Procalcitonin is the most sensitive biomarker for bacterial specificity providing results to determine bacterial infection.
B·R·A·H·M·S Clinical Portal
The B·R·A·H·M·S Clinical Portal is your on-demand training platform for learning about procalcitonin (PCT) testing, from use in differential diagnosis and antibiotic treatment decisions to making bacterial co-infection assessments.
Procalcitonin (PCT) Learning Center
Explore our learning center to find educational resources and FAQs on procalcitonin (PCT) testing, bacterial infections, antibiotic resistance, and more.
References
- Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016 Sep;10(5):394-403.
- Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoularigis J, et al. Reframing the association and significance of co-morbidities in heart failure. Eur J Heart Fail. 2016 Jul;18(7):744-58.
© 2024 Thermo Fisher Scientific, Inc. All rights reserved.
